Captopril ATI medication template fsfdfd PDF

Preview

Summary

medication template for ATI fdfdfdfdfdfdfdfdfdfdfdfdfdfdfdfdfdfd fddf d df df df d dfdf d df d fdd d fdf d dfd df df dfd fdf df ddfd fdf ddf df dfd defd...

Description

ACTIVE LEARNING TEMPLATE:

Medication

STUDENT NAME _____________________________________ MEDICATION Captopril __________________________________________________________________________

REVIEW MODULE CHAPTER ___________

CATEGORY CLASS Antihypertensive ______________________________________________________________________

PURPOSE OF MEDICATION

Expected Pharmacological Action Reduces peripheral arterial resistance in hypertensive patients

Therapeutic Use Reduction in BP

Complications Fever, Angioedema, Hypotension, Hyperkalemia, Nephrotic syndrome, Hyponatremia

Medication Administration Adults to adolescents:Take one hour before meals Initial: 25 mg bid. or tid. Increased to 50 mg b.i.d. or t.i.d. after 1-2 wk Range: 25 mg bid or tid- 450 mg/day

Contraindications/Precautions Combination therapy with a neeprilysin inhibitor or within 36 hrs of switching to or from sacubitril/valsartan; concurrent aliskiren use in patients w/diabetes or patients w/renal impairmentPrecautions: Hypertension, Heart failure, Hyperkalemia

Nursing Interventions Monitor closely patient's BP, Monitor renal function tests fot signs of nephrotic syndrome, Monitor WBC regularly

Interactions ACE inhibitors: Increased risk of hypotension, hyperkalemia, & renal impairmentcyclosporine: Increased risk of hyperkalemiadiuretics: Additive hypotensive effectsActivities: alcohol use: Additive hyptoensive effectsFood: moderate to high potassium-containing foods: Possibly increased risk of hyperkalemia

Client Education Evaluation of Medication Effectiveness Reduction of peripheral arterial resistance in hypertensive patientsIncrease in renal blood flowReductions of blood pressure

ACTIVE LEARNING TEMPLATES

Instruct patient to take captopril 1 hr a.c.; Tell patient to rise slowly from sitting or lying to minimize orthostatic hypotension; Avoid sunlight or wear sunscreen; Warn patient not to stop taking drug abruptly; Urge patient not to use salt substitues that contain potassium; Urge patient to tell prescriber about signs and symptoms of infection; Advise female patient of childbearing age, to notify prescriber immediately if pregnancy occurs

THERAPEUTIC PROCEDURE

A7...